Scholars Central

EditorialPublished 30 Nov 2024

Fecal Microbiota Transplantation (FMT) for Metabolic Disorders Current Insights and Therapeutic Potential

Authors: Lillian Pemberton

Health Science Journal

Volume 18 · Issue 11 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Fecal microbiota transplantation (FMT) has emerged as a novel therapeutic approach for a variety of gastrointestinal and systemic conditions by restoring microbial diversity and modulating gut microbiota composition. Increasing evidence suggests that the gut microbiota plays a pivotal role in the pathogenesis of metabolic disorders, including obesity, type 2 diabetes (T2D), and non-alcoholic fatty liver disease (NAFLD). FMT, which involves transferring fecal matter from a healthy donor to a recipient, has been shown to influence metabolic homeostasis by altering gut microbiota composition, improving insulin sensitivity, and modulating inflammatory pathways. This review explores the mechanisms underlying the impact of FMT on metabolic health, summarizes the current clinical evidence on its efficacy in treating metabolic disorders, and discusses the challenges and future directions for FMT as a therapeutic strategy for metabolic diseases.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Health Science Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHealth Science Journal
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Lillian Pemberton”